In October 2017, Anthem unveiled plans to establish an in-house PBM called IngenioRx. Anthem signed a five-year agreement with CVS Health to manage prescription fulfillment and claims processing for IngenioRx beginning Jan. 1, 2020. The announcement came after Anthem said in April 2017 it would drop its contract with Express Scripts. The decision came during an ongoing legal battle between the two parties.
Anthem has said managing its own PBM will give the health insurer more power to determine which drugs are on its formulary, or its preferred list of prescriptions. During an Oct. 31 third quarter earnings call with analysts, Ms. Boudreaux said IngenioRx will lead to $4 billion in gross pharmacy savings, with most of the savings flowing to members and at least 20 percent heading to shareholders.
“To date, we’ve built and tested thousands of our benefit plans and set up our required technology environments,” Ms. Boudreaux said. “The build-out of our customer service center is ongoing and will be up and running by mid-2019.”
More articles on payers:
Anthem’s Q3 profit jumps 29% to $960M
Prices vary within hospitals: Why patients should price shop payers
4 quick notes about ACA’s 2019 open enrollment period
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
